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ABSTRACT  
Purpose of review: Early rehabilitation is recommended in many guidelines, with limited 
evidence to guide practice. Brain neurobiology suggests early training, at the right dose, will 
aid recovery. In this review we highlight recent trials of early mobilisation, aphasia, 
dysphagia and upper limb treatment where intervention commenced within 7 days of stroke 
and discuss future research directions. 
Recent findings: Trials in this early time window are few. While the seminal AVERT trial 
suggests a cautious approach is necessary immediately (<24 hours) after stroke, early 
mobility training and mobilisation appear well tolerated, with few reasons to delay initiating 
some rehabilitation within the first week. The results of large clinical trials of early aphasia 
therapy are on the horizon, and examples of targeted upper limb treatments with better patient 
selection are emerging.   
Summary: Early rehabilitation trials are complex, particularly those that intervene across 
acute and rehabilitation care settings, but these trials are important if we are to optimise 
recovery potential in the critical window for repair. Concerted efforts to standardise ‘early’ 
recruitment, appropriately stratify participants, and implement longer term follow-up is 
needed. Trial standards are improving. New recommendations from a recent Stroke Recovery 
and Rehabilitation Roundtable will help drive new research. 
Keywords: Stroke, rehabilitation, neurological recovery, mobility, thrombolysis 
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INTRODUCTION 
Early commencement of rehabilitation after stroke is recommended in many clinical practice 
guidelines (1). Recommendations are typically general in nature. Rarely are the specific 
timing, dose or content of rehabilitation interventions defined, which reflects the current 
evidence base.  In principal, there are few good reasons to delay rehabilitation. But to 
progress the field, we need better understanding of what interventions can or should be 
started early, in what dose and using what schedule in order to optimise patient recovery. In 
this review we define ‘early rehabilitation’ as interventions directed at improving post stroke 
impairments or disability that commence within the first 7 days post stroke. We chose the 
first 7 days for several reasons. With average length of acute hospital stay in many Western 
countries around 7 days, for many this period represents first (and for many patients only) 
access to multidisciplinary treatment in an organised stroke service. Around a third of stroke 
patients go on to receive some inpatient rehabilitation, although in lower income countries, 
post-acute stroke rehabilitation services are rare or non-existent.   Secondly, recognising that 
understanding the neural substrates of recovery will help us develop better treatments 
underpinned by biology (2), pre-clinical research suggests that there is an early ‘critical’ or 
‘sensitive’ period in which the brain is most responsive to improvements induced by motor 
training (3), with the first days and weeks important (4).  Motor training started around 5 days 
post stroke is more effective than training started at day 14 or day 30 (5).  Taken together, 
applying targeted treatments within an early sensitive period in a stimulating environment 
should provide the best opportunity of achieving true neurological recovery after stroke (3, 
4). 
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In this review, we highlight recent early intervention trials in early mobility and exercise 
training, speech and language, swallowing and upper limb training. We searched PUBMED 
for full journal articles and searched the Cochrane Stroke Group trials register for trials 
published since 2015 in any of the areas outlined above. We excluded pharmaceutical trials.   
 
Early mobility training, mobilisation and exercise 
While the international, multicentre AVERT trial dominates the trial landscape, interest early 
onset mobility training and mobilisation has resulted in publication of a number of new 
randomised controlled trials (see Table 1) since our 2015 review (1) of the field.  In the 
multicentre SEVEL trial, (6) an early sitting protocol, initiated within one calendar day after 
stroke onset, was compared to a late protocol commenced at day 3 for patients with ischemic 
stroke. Only the timing of first intervention was recorded, not subsequent interventions 
throughout hospitalisation. Primary outcome was modified Rankin Scale (mRS) at 3 months 
post stroke, with medical complications as key secondary outcomes. Patients were recruited 
from 11 French stroke centres and planned sample size was 366 patients. Unfortunately slow 
recruitment (largely due to poor trial infrastrcture) led investigators to close the trial early 
(total sample n=167; early sitting n=82, later n=85). There were no significant differences in 
mRS or complications at 3 months. Complication rates were low overall, and both 
interventions were well tolerated. A Brazilian study by Poletto and colleagues (7) aimed to 
test the safety and feasibility of a protocol commencing within 48 hours of stroke onset 
incorporating sitting out of bed plus 30 minutes of functional training per day led by a 
physiotherapist, 5 days a week compared with usual care (physical therapy generally 
performed in bed and only conducted when requested by staff). Planned recruitment was for 
174 patients (82 per group), with mRS the primary outcome at 3 months post stroke, and 
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feasibility and safety endpoints that included the timing and duration of physical therapy. 
Once again, slow recruitment led investigators to close the study early, with late hospital 
arrival (>48 hours post stroke) cited as the primary reason for the high exclusion rate. Only 
37 participants completed the trial (n=18 early, n=19 usual care). While the intervention was 
feasible with no safety concerns noted, there were no significant differences in any of the 
outcomes.   
[INSERT TABLE 1 HERE] 
Two further randomised controlled trials from India (8) and Italy (9) have also reported in the 
last 12 months. Chippalla and Sharma (8) largely adopted the phase II AVERT protocol (15), 
randomising patients to mobilisation out of bed within 24 hours of stroke onset (n=43), with 
5-30 minutes of upright activities (as tolerated) per day or to usual care (n=43). The Barthel 
Index (BI) was used to assess functional status at 3 months with authors reporting 
significantly greater independence in the intervention group at 3 months compared to patients 
who received lower dose usual care. The investigators in the Italian trial (9), tested early 
versus delayed application of two different approaches to rehabilitation. Using a factorial 
design they compared early proprioceptive neuromuscular facilitation (PNF) or cognitive 
therapeutic exercise (CTE) commenced within 24 hours of admission, with delayed PNF and 
CTE groups, where treatment started 4 days later. A total of 340 patients were randomised 
and follow up occurred at 3 and 12 months. All groups improved over time, with no 
significant differences in mRS or BI between the early and delayed groups or between 
treatment approaches at 3 months.  
Interventions tested in these trials ranged from simple out of bed sitting protocols, to more 
targeted, higher dose training. Many test the feasibility of delivering higher dose 
interventions within their stroke settings. A recent exercise study investigating the feasibility 
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of ‘intensive’ treadmill training within 2 days of onset of stroke symptoms, though small 
(n=25), is worth noting (11). Rarely is cardiovascular fitness a training target in the early time 
window. Thirty minutes of treadmill training, with bodyweight support as needed, twice daily 
for 5 consecutive days was the intervention target. This mild stroke cohort (median NIHSS 6, 
IQR 3-8) completed 88% of training sessions with non-serious adverse events (dizziness, leg 
pain) recorded in around 15% of training sessions. While the intervention was feasible and 
increased physical activity overall, few patients achieved the target exercise intensity of 50% 
heart rate reserve. Loss of cardiovascular fitness is presumed to be rapid after stroke. Larger 
trials of early exercise interventions to mediate this loss are expected. 
 
Collectively, the randomised trials above add a further 630 patients from 4 countries to our 
planned 2009 Cochrane review update. AVERT will however dominate the meta-analysis, 
contributing 2,104 patients from 56 sites in 5 countries. Our main trial results for AVERT 
were reported in The Lancet early in 2015 (10), with our pre-specified dose-response analysis 
and process evaluation published more recently (16-18). To briefly recap, AVERT compared 
a frequent, higher dose of out of bed mobility based training protocol(on top of usual care) 
started within 24 hours of stroke onset and continued for 14 days or until discharge, to usual 
care alone. Primary outcome was mRS at 3 months. We found that the higher dose protocol 
resulted in lower odds of a favourable outcome at 3 months (mRS 0-2) compared with usual 
care, which also started at a median time of 22.4 hours post stroke. This finding surprised 
many. Importantly our results call into question the common therapeutic axiom that ‘more is 
better’, particularly in the very early time window after stroke (3, 10, 19). Further, our results 
highlight our need to better understand the biology of recovery and human response to 
training in the early post stroke period when the critical period is believed to exist. Our 
exploratory sub-group analyses of the primary outcome (10) found no significant treatment-
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by-subgroup interactions, although patients with severe stroke (NIHSS > 16, n=291) and 
those with ICH (n=255) showed less favourable outcomes when treated with the higher 
intensity regimen. Interestingly, those treated with intravenous rtPA (n=503) were no 
different in their response to treatment. While further pre-specified analyses are ongoing, 
particularly around safety, later outcomes and cost (16, 20), our dose-response analysis 
results suggest that while higher amounts of training have a deleterious effect on outcome 
(mRS at 3 months, walking recovery, death), higher frequency of intervention is associated 
with more favourable outcome (17). These findings provide a new direction for future 
studies, suggesting both training thresholds and scheduling may be important in the very 
early period (19). Whether we should avoid any activity in the first day(s) post stroke is 
currently unknown. The favourable outcome and low complication rates experienced by 
patients in the usual care group in AVERT who also started some activity out of bed early 
suggests that a ban on out of bed activity is unwarranted. The current HeadPoST (21) cluster 
trial in which patients spend 24 hours after admission flat may provide further insights to 
guide practice.  
 
Thrombolysis and early mobilisation 
We included patients treated with rtPA (alteplase) in AVERT; it is standard of care, and 
protocols restricting patients to bed for 24 hours are not evidence-based. Recently, a detailed 
observational study (n=18) by Arnold et al (22) examined the safety profiles of ischemic 
stroke patients commencing out of bed mobilisation and rehabilitation between 13-23 hours 
post treatment with intravenous rtPA. No serious bleeding complications were found, 
although one patient experienced transient neurological changes with mobilisation, which 
resolved with rest. No long term outcomes were examined. At the other end of the spectrum, 
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a recent large (n=6153) retrospective study of those treated with intravenous  rtPA by 
Momsaki et al (23) examined the association between starting rehabilitation (any physical or 
occupational therapy) within 3 days of admission and functional independence (mRS 0-2) at 
hospital discharge. Using a Japan-wide hospital database, and adjusting for age, sex, type of 
ischemic stroke, baseline mRS, comorbidities and process factors (admission day, unit size 
etc), the authors found significantly higher levels of independence in those receiving early 
rehabilitation and no differences in mortality or the incidence of haemorrhage.  It remains 
unclear if rapid mobilisation or rehabilitation is desirable after rtPA treatment and whether 
successful recanalization following treatment has an important influence.  
 
Early dysphagia and aphasia treatment 
Unlike early mobilisation, which has seen a flurry of trial activity in the last 12 months, we 
found only one recent small trial of early dysphagia treatment with rTMS (24). In this 3-arm 
trial, 3Hz (n=15), 1 Hz (n=13) and sham rTMS (n=12) was applied to patients recruited a 
median of 6-9 days from stroke onset over 5 consecutive days. The primary outcome, 
Standardised Swallowing Assessment (SSA), was assessed by a blinded neurologist at 3 
months. The authors found a significant improvement in SSA in both treatment groups that 
was retained to 3 months, but no change in the sham rTMS group. No harms were reported. 
The longer follow up period and retention of effect found here suggest it may be time for 
larger trials of rTMS for dysphagia treatment. 
 
We identified 2 protocols for trials of early aphasia interventions (13, 14). The Rotterdam 
Aphasia Therapy Study-3 (RATS-3) (14) compares communication outcomes in people with 
first-ever acute stroke (n=150) following early intensive cognitive-linguistic therapy starting 
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before day 14 and those who received usual care aphasia therapy starting after day 30. This 
multicentre trial closed late in 2015 and results are under review. The Very Early 
Rehabilitation in SpEech (VERSE) trial is ongoing with full recruitment (n=246) expected in 
2017 (13). The VERSE trial is testing whether two forms of daily, prescribed aphasia therapy 
for 20 sessions, beginning within 14 days of acute stroke, is more effective and cost saving 
than usual care at three months. Both trials begin aphasia intervention within the first week 
post-stroke. Intervention continues into sub acute recovery for four weeks, according to the 
ongoing therapeutic needs of stroke survivors. Exemplary collaboration between acute care, 
rehabilitation and community healthcare sites (and multiple ethics applications) are essential 
to achieve seamless clinical care and delivery of research outcomes. The challenge of 
interventions that span acute/rehabilitation/community care is a major barrier to early 
rehabilitation trials.  The results of these trials are eagerly awaited.   
 
Early upper limb rehabilitation 
In the EXPLICIT-Stroke program trials, recruitment occurred an average of 8 days post 
stroke (12). Two interventions were tested; for patients with a favourable prognosis, a 
modified 3 week contraint induced movement therapy (mCIMT) program (n=29) was 
compared to usual care (n=29), while those with unfavourable prognosis were allocated to a 3 
week EMG-NMS program (n=50) or usual care (n=51).  The primary outcome for both trials 
was the ARAT score with final follow up at 26 weeks. The mCIMT program was more 
effective at improving function than usual care early, but effects were not sustained at 26 
week. There was no benefit of EMG-NMS in those with poorer prognosis over usual care. 
Nested imaging and transcranial magnetic simulation (TMS) studies to examine brain 
recovery characteristics in 30 patients from each of the prognostic groups are planned (25). 
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In this review we have identified some of the challenges of rehabilitation research in the early 
time window. Rehabilitation trials are complex, often requiring input from multidisciplinary 
teams. Standardised, early recruitment is vital to improving the quality of our trials. How we 
stratify and select patients in recovery trials is not a trivial question. If we consider the 
benefits to be gained from careful, imaging based selection in many acute stroke trials, it is 
clear that we need to strive for more sophisticated approaches to patient selection. One 
example of an approach to determine the recovery potential of the upper limb based on 
remaining neurobiological characteristics is the PREP algorithm (26). An important 
distinction of this approach is that it is step down, pulling in brain imaging techniques (e.g., 
transcranial magnetic stimulation and magnetic resonance imaging) only when they have the 
potential to add information over and above what can be derived from clinical outcome 
measures. This approach has the potential to improve patient selection for upper limb 
intervention trials and be extended to other domains. At present however, our understanding 
of who recovers, who doesn’t and why in response to treatment is incomplete and remains a 
priority. 
 
CONCLUSION 
Rehabilitation research has come a long way in recent years, but still has a long way to go. 
This year the first Stroke Recovery and Rehabilitation Roundtable was held with 60 world 
stroke experts. Our goal was to develop recommendations for standardisation and improved 
research practice in key areas; pre-clinical research, biomarkers, clinical trial outcomes, and 
intervention development and monitoring (2). Recommendations will be available early 2017. 
An important discussion point at the meeting was the need to start interventions earlier 
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(during the critical window), and to apply them at the right dose to improve the potential for 
neurological recovery and repair. It is exciting to see the benefit of new intra-arterial 
treatments, which improve not just global disability (mRS), but aphasia and other motor 
outcomes (27). Like acute stroke, we need to discover a game-changing treatment(s) that 
improves the potential for true recovery in the thousands of stroke survivors battling 
disability each year. Breakthrough interventions are likely to be multi-modal (3, 4). Such a 
discovery would kick start the next series of focused studies that will change the recovery 
landscape forever.  
 
KEY POINTS 
1. An early sensitive or critical period for recovery is likely in humans, we need to 
develop rehabilitation treatments that harness potential for recovery. 
2. Interest in early mobility training and mobilisation evidenced by flurry of new trials in 
the first days post stroke 
3. Challenges of conducting trials of early rehabilitation interventions are highlighted in 
this review 
4. Several large early aphasia trials will be reporting in next 18 months 
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Table 1. Recent rehabilitation trials where the intervention was started within 7 days of stroke onset*   
Trial Randomis
ed sample 
Time 
between 
stroke and 
intervention 
Intervention group Comparison group/s Primary Results 
Mobilisation      
Herisson et al 2016 (6) 
SEVEL  
France 
 
167 < 24 hours 
 
Early sitting: seated out of bed within 
24 hours  
Dose: ≥15min /day,  as tolerated 
Progressive sitting: positioned in bed 
at 30 degrees in first 24 hours, 
progressing to sitting out of bed by day 
3 
Dose: ≥15min for first sitting 
mRS score of 0-2 at 3 
months: 
Early sitting = 76.2% 
Progressive sitting =  
77.3%  
ns 
Poletto et al 2015 (7) 
Brazil 
39 < 48 hours Intervention: focused on sitting out of 
bed or standing, and physical therapy.  
Dose: 30min, 1/day, 5/week plus 
sitting out of bed whenever possible 
for first 14 days, or until discharge 
Control group: routine hospital care, 
including conventional physical 
therapy  
Dose: Varied between patients, usually 
15min sessions 
mRS score of 0-2 at 3 
months: 
no diff between groups, 
Feasibility and safety:  
no complications in either 
group 
Chippalla and Sharma 
2015 (8) 
India 
86 < 24 hours Very Early Mobilisation (VEM): Usual 
care plus out of bed activities 
including sitting, standing and walking  
Dose: 5-30min, depending on 
tolerance, ≥2/day, ≤7 days 
Usual care: routine stroke unit care  
Dose: 45 min/a day, ≤7 days or until 
discharge 
Independent on Barthel 
Index at 3 months: 
Intervention = 85% 
Usual Care = 45% 
p<0.01 
 
Table 1
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Morreale et al 2016 (9) 
Italy 
340 < 24 hours Early rehabilitation: daily out of bed 
activity with either (1) proprioceptive 
neuromuscular facilitation (PNF), or 
(2) Cognitive therapeutic exercise 
(CTE)  
Dose: 1 hour/day for first 4 days; 
followed by 2.25hours/day, daily for 
14 weeks; followed by 1.5 hours/day, 
5 days/week until final medical follow 
up (mean of 38 weeks) 
Usual care: routine hospital care for 
first 4 days, followed by either (1) 
PNF or (2) CTE 
Dose: standard hospital care for first 4 
days; from day 5, as per early 
rehabilitation groups 
mRS at 3 months:  
No difference between 
groups 
ns 
Bernhardt et al 2015 (10) 
AVERT  
Australia 
2104 < 24 hours Early mobilization (VEM): Emphasis 
on patient being upright and out of bed 
(sitting or standing). 
Dose: ≥2/day for first 14 days, or until 
discharge 
Usual care: usual care provided by 
hospital  
Dose: as per usual care of individual 
sites 
mRS of 0-2 at 3 months: 
VEM = 46% 
Usual Care = 50% 
OR=.73, p=.004 
Exercise      
Strømmen et al 2016 (11) 
Denmark  
25 
included# 
 Intervention: walking on a treadmill, 
with body weight supported, target 
intensity of 50% heart rate reserve  
Dose: 30min, 2/day, ≤5 days, plus 2 
sessions 30 days after inclusion 
N/A Number of sessions 
completed: 
97% of intended training 
sessions were intiated 
88% of sessions 
completed 
Upper limb      
Kwakkel et al (12) 
EXPLICIT-Stroke 
Netherlands 
159 Average of 
8 days 
Upper limb intervention: either (1) 
modified constraint induced therapy 
[mCIMT] or (2) electromyography-
triggered neuromuscular stimulation 
[EMG-NMS]. 
Dose: 60min/day in 1-2 sessions, ≥3 
weeks 
Usual care: conventional upper limb 
therapy as provided by Physical 
Therapist  
Dose: 30min/day for 3 weeks 
Action Research Arm Test at 
5 weeks: 
mCIMT – usual care = 
1.757,  p=.01   
EMG-NMS – usual care = 
-0.63, ns 
Aphasia      
3 
 
Godecke et al 2016 (13) 
VERSE 
Australia 
ANZCTR Register: 
2613000776707 
Target 
sample: 
246 
< 14 days VERSE Therapy: usual care, plus a 
structured aphasia therapy program  
Dose: 45-60 min/session, 3-5 
sessions/week, until total of 20 
sessions 
Comparison groups: either (1) Usual 
care along or (2) Usual care plus 
additional speech therapy as decided 
by treating therapist  
Dose: Additional therapy matched to 
intervention group 
NA – In progress 
Nouwens et al (14) 
RATS3 
Netherlands 
Dutch Trial Register: 
NTR3271 
Target 
sample: 
150 
< 2 weeks Early speech therapy: Within two 
weeks of stroke cognitive-linguistic 
therapy including either (1) 
Phonological program or or (2) 
semantic program  
Dose: ≤7 hours/week 
Delayed speech therapy: no therapy 
until four weeks post stroke  
Dose: Nil 
NA – Under review 
*For speech therapy trials, those starting therapy within two weeks of stroke onset were included 
# Single group study, no randomisation 
OR = Odds ratio, ns = non-significant 
